Celebrex Medication Labeling information

This section provides information on past and present label descriptions for the Celebrex medication.

These Celebrex medication labels include the pharmacological breakdown, chemical structure, warnings, indications, precautions, pharmcokinetics, and contraindications for the use of the Celebrex medication.

Pfizer submitted two seperate New Drug Applications (NDA's) to the FDA for it's Celebrex medication, so some of these documents are only for one or the other.

Both Celebrex Medication NDAs:

Questions and Answers Celebrex labeling change - warfarin interaction

Celebrex Labeling Changes June 7, 2002

Celebrex Medication NDA: 020998

Weitz & Luxenberg is no longer accepting Celebrex cases.

see also:

Label: 12/23/1999 Celebrex Labeling Description December 23, 1999
Official FDA labeling description of Celebrex from December 23, 1999

Label: 1/9/2004 Celebrex Labeling Description: 1/9/2004
Official FDA labeling description of Celebrex from January 9, 2004

Official Documents Celebrex Public Comment
Official Comments on the Risks and Side Effects of Celebrex